| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $418.6M | +20.0% |
| Cost of Revenue | $73.0M | +21.5% |
| Gross Profit | $345.6M | +19.7% |
| R&D Expense | $15.1M | +22.3% |
| SG&A Expense | $266.2M | +18.3% |
| Operating Income | $63.9M | +8.5% |
| Pre-tax Income | $66.3M | +15.7% |
| Income Tax | $17.7M | +15.6% |
| Net Income | $48.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $166.1M | +59.1% |
| Accounts Receivable | $75.7M | +35.6% |
| Inventory | $25.3M | +6.4% |
| Current Assets | $277.5M | +44.6% |
| Total Assets | $342.7M | +29.8% |
| Current Liabilities | $64.3M | +40.9% |
| Long-term Debt | $18.0M | -5.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $74.0M | +11.8% |
| Investing Cash Flow | -$6.9M | +28.1% |
| Financing Cash Flow | -$5.4M | +84.2% |
| +14.5% |
| EPS (Basic) | $0.33 | +13.8% |
| EPS (Diluted) | $0.32 | +14.3% |
| Total Liabilities |
| $86.1M |
| +21.6% |
| Stockholders' Equity | $256.5M | +32.9% |